AAPL344.63-4.28 (-1.23%) ▼|ABBV294.89+4.10 (+1.41%) ▲|ABT106.22+1.65 (+1.57%) ▲|ACN258.79+11.57 (+4.68%) ▲|ADBE250.53+2.41 (+0.97%) ▲|AMAT389.01-32.66 (-7.74%) ▼|AMD503.68-62.74 (-11.08%) ▼|AMGN466.34+5.61 (+1.22%) ▲|AMT187.89+2.01 (+1.08%) ▲|AMZN240.14-3.65 (-1.50%) ▼|AVGO325.85-19.15 (-5.55%) ▼|AXP319.13-4.59 (-1.42%) ▼|BA171.56-1.09 (-0.63%) ▼|BAC50.03-1.12 (-2.18%) ▼|BKNG148.13-2.30 (-1.53%) ▼|BLK1,147.34-28.90 (-2.46%) ▼|BMY62.47+1.08 (+1.76%) ▲|BNY147.13-2.24 (-1.50%) ▼|BRK-B543.36+1.40 (+0.26%) ▲|C121.16-4.60 (-3.66%) ▼|CAT618.86-28.53 (-4.41%) ▼|CL95.90+2.74 (+2.94%) ▲|CMCSA23.09+0.82 (+3.68%) ▲|COF202.74-6.00 (-2.87%) ▼|COP153.47+3.44 (+2.29%) ▲|COST1,017.00+22.39 (+2.25%) ▲|CRM228.71-2.19 (-0.95%) ▼|CSCO103.70-4.89 (-4.50%) ▼|CVS90.27-0.06 (-0.07%) ▼|CVX235.43+3.97 (+1.71%) ▲|DE675.70+15.70 (+2.38%) ▲|DHR232.30-4.68 (-1.97%) ▼|DIS110.96+0.05 (+0.05%) ▲|DUK127.42+1.52 (+1.21%) ▲|EMR164.94-5.80 (-3.40%) ▼|FDX313.28+5.46 (+1.77%) ▲|GD372.61+1.79 (+0.48%) ▲|GE301.83-11.22 (-3.58%) ▼|GEV857.75-30.10 (-3.39%) ▼|GILD170.68+5.07 (+3.06%) ▲|GM87.40+1.68 (+1.96%) ▲|GOOG278.22-4.10 (-1.45%) ▼|GOOGL279.84-3.98 (-1.40%) ▼|GS894.45-33.28 (-3.59%) ▼|HD329.20+0.22 (+0.07%) ▲|HON218.33-3.81 (-1.72%) ▼|IBM257.81-0.47 (-0.18%) ▼|INTC65.76-26.31 (-28.58%) ▼|INTU341.09+9.90 (+2.99%) ▲|ISRG432.01-16.75 (-3.73%) ▼|JNJ273.20-2.00 (-0.73%) ▼|JPM337.04-6.54 (-1.90%) ▼|KO94.08+1.26 (+1.36%) ▲|LIN514.24+11.09 (+2.20%) ▲|LLY1,417.54+43.84 (+3.19%) ▲|LMT636.95-6.64 (-1.03%) ▼|LOW209.07+1.79 (+0.86%) ▲|LRCX239.11-15.28 (-6.01%) ▼|MA638.01+2.31 (+0.36%) ▲|MCD258.12+0.74 (+0.29%) ▲|MDLZ64.94+2.41 (+3.85%) ▲|MDT96.54-0.57 (-0.59%) ▼|META614.99-9.53 (-1.53%) ▼|MMM174.34-3.02 (-1.70%) ▼|MO78.03+1.28 (+1.67%) ▲|MRK149.52+3.19 (+2.18%) ▲|MS184.30-4.55 (-2.41%) ▼|MSFT521.91-8.23 (-1.55%) ▼|MU884.74-49.53 (-5.30%) ▼|NEE83.65+1.51 (+1.84%) ▲|NFLX61.82-0.23 (-0.37%) ▼|NKE38.59+0.17 (+0.43%) ▲|NOW104.94-4.73 (-4.31%) ▼|NVDA203.24-10.43 (-4.88%) ▼|ORCL130.67-8.89 (-6.37%) ▼|PEP137.34+3.55 (+2.65%) ▲|PFE30.52+0.57 (+1.90%) ▲|PG161.57+0.98 (+0.61%) ▲|PLTR184.11-12.31 (-6.27%) ▼|PM208.79+0.29 (+0.14%) ▲|QCOM164.68-20.73 (-11.18%) ▼|RTX199.80+0.40 (+0.20%) ▲|SBUX104.74-0.77 (-0.73%) ▼|SCHW87.70-1.77 (-1.98%) ▼|SO94.17+1.18 (+1.27%) ▲|SPG217.80+2.08 (+0.96%) ▲|T21.43+0.51 (+2.44%) ▲|TMO696.97-12.21 (-1.72%) ▼|TMUS156.44+9.15 (+6.21%) ▲|TSLA399.81-3.49 (-0.87%) ▼|TXN300.84-10.58 (-3.40%) ▼|UBER65.25-0.49 (-0.75%) ▼|UNH406.97-3.94 (-0.96%) ▼|UNP304.00+2.07 (+0.69%) ▲|UPS108.25+0.92 (+0.86%) ▲|USB59.45-1.19 (-1.96%) ▼|V413.59+3.05 (+0.74%) ▲|VZ44.73+1.07 (+2.45%) ▲|WFC83.40-1.41 (-1.66%) ▼|WMT123.51+2.26 (+1.86%) ▲|XOM187.25+3.96 (+2.16%) ▲|AAPL344.63-4.28 (-1.23%) ▼|ABBV294.89+4.10 (+1.41%) ▲|ABT106.22+1.65 (+1.57%) ▲|ACN258.79+11.57 (+4.68%) ▲|ADBE250.53+2.41 (+0.97%) ▲|AMAT389.01-32.66 (-7.74%) ▼|AMD503.68-62.74 (-11.08%) ▼|AMGN466.34+5.61 (+1.22%) ▲|AMT187.89+2.01 (+1.08%) ▲|AMZN240.14-3.65 (-1.50%) ▼|AVGO325.85-19.15 (-5.55%) ▼|AXP319.13-4.59 (-1.42%) ▼|BA171.56-1.09 (-0.63%) ▼|BAC50.03-1.12 (-2.18%) ▼|BKNG148.13-2.30 (-1.53%) ▼|BLK1,147.34-28.90 (-2.46%) ▼|BMY62.47+1.08 (+1.76%) ▲|BNY147.13-2.24 (-1.50%) ▼|BRK-B543.36+1.40 (+0.26%) ▲|C121.16-4.60 (-3.66%) ▼|CAT618.86-28.53 (-4.41%) ▼|CL95.90+2.74 (+2.94%) ▲|CMCSA23.09+0.82 (+3.68%) ▲|COF202.74-6.00 (-2.87%) ▼|COP153.47+3.44 (+2.29%) ▲|COST1,017.00+22.39 (+2.25%) ▲|CRM228.71-2.19 (-0.95%) ▼|CSCO103.70-4.89 (-4.50%) ▼|CVS90.27-0.06 (-0.07%) ▼|CVX235.43+3.97 (+1.71%) ▲|DE675.70+15.70 (+2.38%) ▲|DHR232.30-4.68 (-1.97%) ▼|DIS110.96+0.05 (+0.05%) ▲|DUK127.42+1.52 (+1.21%) ▲|EMR164.94-5.80 (-3.40%) ▼|FDX313.28+5.46 (+1.77%) ▲|GD372.61+1.79 (+0.48%) ▲|GE301.83-11.22 (-3.58%) ▼|GEV857.75-30.10 (-3.39%) ▼|GILD170.68+5.07 (+3.06%) ▲|GM87.40+1.68 (+1.96%) ▲|GOOG278.22-4.10 (-1.45%) ▼|GOOGL279.84-3.98 (-1.40%) ▼|GS894.45-33.28 (-3.59%) ▼|HD329.20+0.22 (+0.07%) ▲|HON218.33-3.81 (-1.72%) ▼|IBM257.81-0.47 (-0.18%) ▼|INTC65.76-26.31 (-28.58%) ▼|INTU341.09+9.90 (+2.99%) ▲|ISRG432.01-16.75 (-3.73%) ▼|JNJ273.20-2.00 (-0.73%) ▼|JPM337.04-6.54 (-1.90%) ▼|KO94.08+1.26 (+1.36%) ▲|LIN514.24+11.09 (+2.20%) ▲|LLY1,417.54+43.84 (+3.19%) ▲|LMT636.95-6.64 (-1.03%) ▼|LOW209.07+1.79 (+0.86%) ▲|LRCX239.11-15.28 (-6.01%) ▼|MA638.01+2.31 (+0.36%) ▲|MCD258.12+0.74 (+0.29%) ▲|MDLZ64.94+2.41 (+3.85%) ▲|MDT96.54-0.57 (-0.59%) ▼|META614.99-9.53 (-1.53%) ▼|MMM174.34-3.02 (-1.70%) ▼|MO78.03+1.28 (+1.67%) ▲|MRK149.52+3.19 (+2.18%) ▲|MS184.30-4.55 (-2.41%) ▼|MSFT521.91-8.23 (-1.55%) ▼|MU884.74-49.53 (-5.30%) ▼|NEE83.65+1.51 (+1.84%) ▲|NFLX61.82-0.23 (-0.37%) ▼|NKE38.59+0.17 (+0.43%) ▲|NOW104.94-4.73 (-4.31%) ▼|NVDA203.24-10.43 (-4.88%) ▼|ORCL130.67-8.89 (-6.37%) ▼|PEP137.34+3.55 (+2.65%) ▲|PFE30.52+0.57 (+1.90%) ▲|PG161.57+0.98 (+0.61%) ▲|PLTR184.11-12.31 (-6.27%) ▼|PM208.79+0.29 (+0.14%) ▲|QCOM164.68-20.73 (-11.18%) ▼|RTX199.80+0.40 (+0.20%) ▲|SBUX104.74-0.77 (-0.73%) ▼|SCHW87.70-1.77 (-1.98%) ▼|SO94.17+1.18 (+1.27%) ▲|SPG217.80+2.08 (+0.96%) ▲|T21.43+0.51 (+2.44%) ▲|TMO696.97-12.21 (-1.72%) ▼|TMUS156.44+9.15 (+6.21%) ▲|TSLA399.81-3.49 (-0.87%) ▼|TXN300.84-10.58 (-3.40%) ▼|UBER65.25-0.49 (-0.75%) ▼|UNH406.97-3.94 (-0.96%) ▼|UNP304.00+2.07 (+0.69%) ▲|UPS108.25+0.92 (+0.86%) ▲|USB59.45-1.19 (-1.96%) ▼|V413.59+3.05 (+0.74%) ▲|VZ44.73+1.07 (+2.45%) ▲|WFC83.40-1.41 (-1.66%) ▼|WMT123.51+2.26 (+1.86%) ▲|XOM187.25+3.96 (+2.16%) ▲|
16 C
New York
Friday, October 30, 2026

Tag: health

newsFORsourcecompanycontentinformationreleases1market

Notable introduces Flow Compass, giving healthcare operators control of their AI workforce

Healthcare operators can now conversationally ask what's working in their automations, what's at risk, and what to do next, and get answers grounded in...

Lilly’s Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative...

Building on Omvoh's approved use and durable efficacy in adults, Lilly plans to submit these data to global regulators to support a potential label...

AbbVie Presents Data for ABBV-466, a Novel Dual-Targeting Therapy Demonstrating Higher Endoscopic Remission Rates Than Either Anti-IL-23 or Anti-α4β7 Monotherapy in Moderate to Severe...

In a Phase 2a study, ABBV-466 achieved higher endoscopic remission rates in patients with Crohn's disease than either anti-IL-23 p19 or anti-α4β7 monotherapy at...

Boots Group Finco L.P. and The Boots Group Luxco S.à r.l. Announce Launch of Consent Solicitation for their €650,000,000 5.375% Senior Secured Notes due...

LONDON, Oct. 19, 2026 /PRNewswire/ -- Boots Group Finco L.P. and The Boots Group Luxco S.à r.l. (together, the "Co-Issuers") today announced that they...

Boots Group Finco L.P. and The Boots Group Luxco S.à r.l. Announce Launch of Consent Solicitation for their €650,000,000 5.375% Senior Secured Notes due...

LONDON, Oct. 19, 2026 /PRNewswire/ -- Boots Group Finco L.P. and The Boots Group Luxco S.à r.l. (together, the "Co-Issuers") today announced that they...

Ultima Genomics Selected for Landmark Large-Scale Immune Profiling Study with IMU Biosciences, UK Biobank and Waters Corporation

IMU Biosciences and UK Biobank will generate a single-cell immune profiling AI foundational dataset from 80,000 blood samples collected from UK Biobank participants using Ultima...

Can Multigenerational Community Networks Solve America’s Senior Care Crisis? “All Access hosted by Andy Garcia” Examines Ascentria Care Alliance

A new educational segment explores how interconnected social services, workforce development, and immigrant integration address systemic healthcare shortages across New England.BOSTON, Oct. 19, 2026...

Canara HSBC Life Insurance Introduces ‘Global Wealth Plan’ on Policybazaar, Offers Access to Insurance Linked Global Investing Opportunities

A USD-denominated unit-linked life insurance plan, offered through GIFT City, provides access to global equity, precious metals like Gold/Silver and debt funds across three...

One of ASEAN’s Largest Japanese F&B Exhibitions Returns for Its 14th Edition

SINGAPORE, Oct. 15, 2026 /PRNewswire/ -- Food Japan 2026, ASEAN's premier exhibition for Japanese food and beverage (F&B) products, technology and services, officially opened...

ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Negative Breast Cancer

SHANGHAI, Oct. 18, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present Phase II clinical...

Newmark Releases Q3 2026 Seoul Office Market Report

Seoul Grade A Office Vacancy Reaches 4.5% as Tenant Relocations Drive Diverging Leasing Performance Across Submarkets and AssetsSEOUL, South Korea, Oct. 19, 2026 /PRNewswire/...

AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio

New and updated data across seven assets in lung, colorectal, ovarian, prostate and gastric cancers underscore the potential of AbbVie's oncology portfolio to address diverse...

Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress

First Phase 1 data for sofetabart mipitecan, Lilly's investigational FRα-targeting ADC, in platinum-sensitive ovarian cancer to be featured in a rapid oral presentationUpdated first-line...

Changes to the Board of Directors of H. Lundbeck A/S

Dorothea Wenzel, Chair of the Board, has informed the Board that she will step down in connection with the Annual General Meeting in 2027. Following...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsHealth

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers